Clinical Pain Points
Patients with gastroesophageal reflux disease (GERD) who rely on long-term proton pump inhibitor (PPI) therapy may only achieve symptomatic relief. Nearly 25% of patients respond poorly to medication, requiring lifelong continuous treatment, which imposes a significant therapeutic burden and carries potential risks of drug-related side effects.
Traditional fundoplication surgery permanently alters the native anatomy of the stomach and is associated with irreversible complications such as bloating and persistent dysphagia. Its applicability is limited, particularly in patients with early-stage or mild disease.
Current treatment modalities are unable to provide long-term, stable prevention of gastric acid reflux while preserving normal physiological functions such as swallowing, belching, and vomiting. There is a lack of a minimally invasive, reversible, and standardized implantable solution.





+86-574-63729798
overseas@senscure.net
Block B, Building 3, No.777 Binhai 4th Road, Hangzhou Bay New District, Ningbo 315336, Zhejiang Province, China